Back to products
Thyroid Cancer
- All products
- Hepatitis B Virus28 products
Bladder Cancer39 products
Breast Cancer38 products
- Colorectal Cancer28 products
Diabetic25 products
- Endometrial Cancer29 products
- Hepatitis C Virus21 products
- Leukaemia3 products
- ONCOLOGY PRODUCTS29 products
- Rectal Cancer16 products
- Solid Tumor6 products
- Taskin50 products
- Anti-Diabetic6 products
- BEST SELLER16 products
- Bladder Cancer19 products
- Breast Cancer19 products
- Colon & Rectal Cancer12 products
- Colorectal Cancer10 products
- Diabetic12 products
- Endometrial Cancer13 products
- Hepatitis B Virus7 products
- Hepatitis C Virus9 products
- Ibrutinib4 products
- Kidney Cancer22 products
- Leukaemia12 products
- Liver Cancer22 products
- Lung Cancer24 products
- Lymphoma13 products
- Mantle Cell Lymphoma11 products
- Melanoma12 products
- Non-Hodgkin7 products
- ONCOLOGY18 products
- ONCOLOGY PRODUCTS41 products
- Tumor2 products
CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
CRIZONIX 250 MG
Crizonix Capsule 250 mg Indications Crizotinib is a kinase inhibitor indicated for the treatment of patients with- Metastatic non-small cell lung
ELBONIX 50 MG
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
ELOPAG 25 MG
Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis
ELOPAG 50 MG
Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd. Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic
ELTROM 25 MG
DESCRIPTION ELTROM Eltrombopag 25MG Julphar Bangladesh Ltd. Composition: Eltrom Tablet: Each film coated tablet contains Eltrombopag Olamine INN equivalent to
HERNIX 40 MG
Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of
IBRUXEN 140 MG
Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with
LAPANIX 250 MG
LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase
LARONIB 25 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LENVANIX 10 MG
Lenvanix (lenvatinib) 10 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
LENVANIX 4 MG
Lenvanix (lenvatinib) 4 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
